Article Sidebar
Published:
Mar 1, 2023
Keywords:
AVES Editorial Office
How to Cite
Rahmi Aslan, Özlen Atuğ, Haner Direskeneli, Tülin Ergun, Yeşim Özen Alahdab, Dilek Seçkin, … Haluk Tarık Kani. (2023). RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology, 34(3), 310–310. Retrieved from https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/4414
Main Article Content
Rahmi Aslan
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Özlen Atuğ
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Haner Direskeneli
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Tülin Ergun
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Yeşim Özen Alahdab
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Dilek Seçkin
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Mehmet Pamir Atagündüz
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Nevsun İnanç
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Fatma Alibaz Öner
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
İlkay Ergenç
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Gizem Sevik
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Seda Kutluğ Ağaçkıran
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Kerem Yiğit Abacar
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Fuad Jafarov
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Shahin Mehdiyev
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Elif Cömert Özer
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Murat Karabacak
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Haluk Tarık Kani
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy
Main Article Content
Rahmi Aslan
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Özlen Atuğ
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Haner Direskeneli
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Tülin Ergun
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Yeşim Özen Alahdab
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Dilek Seçkin
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Mehmet Pamir Atagündüz
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Nevsun İnanç
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Fatma Alibaz Öner
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
İlkay Ergenç
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Gizem Sevik
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Seda Kutluğ Ağaçkıran
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Kerem Yiğit Abacar
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Fuad Jafarov
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Shahin Mehdiyev
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Elif Cömert Özer
Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey
Murat Karabacak
Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Haluk Tarık Kani
Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
Abstract
Cite this article as: Ergenç İ, Kani HT, Karabacak M, et al. RE: risk of HBV reactivation in HBsAg negative and anti-HBc IgG positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):310.